This inventor holds 1 USPTO granted patent. Top assignee: Dong-A St Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Iksoo Jang: Innovator in Pharmaceutical Compounds
Introduction
Iksoo Jang is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as GCN2 inhibitors. His work is crucial for advancing treatments for diseases related to GCN2 activity.
Latest Patents
Iksoo Jang holds 1 patent for his innovative work titled "Compounds as GCN inhibitors, pharmaceutical compositions and uses thereof." This patent details novel compounds, specifically those of Formula (I), which act as GCN2 inhibitors. The pharmaceutical compositions he has developed can inhibit GCN2 activity, offering potential treatments for various diseases associated with this pathway.
Career Highlights
Jang is currently employed at Dong-a ST Co., Ltd., where he continues to focus on pharmaceutical innovations. His expertise in developing GCN2 inhibitors positions him as a key player in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Iksoo Jang has collaborated with notable colleagues, including Cheonhyoung Park and Kimoon Ryu. These partnerships enhance the research and development efforts within his field.
Conclusion
Iksoo Jang's contributions to pharmaceutical compounds and his innovative patent work highlight his importance in the industry. His ongoing research promises to impact the treatment of diseases related to GCN2 activity significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile